Schizophrenia is a chronic (long-lasting) condition that changes how a person thinks, acts and feels. It is thought that about 1% of the population lives with this condition. There is no single cause of schizophrenia, but certain things like family history, genetics and chemicals in the brain can all be potential risk factors. This new clinical trial aims to understand if an investigational drug could be safe and potentially effective in impacting attention and memory in people living with cognitive impairment associated with schizophrenia (CIAS).
*This study is for people who:
-- Have been diagnosed with schizophrenia for at least two years
-- Are 18 to 55 years of age
-- Have a dedicated study partner – someone who sees them at least 2 times a week and can accompany them to certain visits
*Other eligibility criteria also apply
Learn more! #sponsored #cureclick
#medicalresearch #ctr #sponsored #ad #promotion #paidpromotion #sp #sponsoredpost #cureclick
